Insulin maker Novo Nordisk raises full-year targets

37



Danish pharmaceuticals group Novo Nordisk, the world’s leading insulin maker, said Wednesday it is raising its full-year profit targets after sales of its anti-obesity and diabetics treatments boosted its bottom line in the third quarter.

The post Insulin maker Novo Nordisk raises full-year targets appeared first on The Guardian Nigeria News – Nigeria and World News.



Source: Guardian Newspaper

Get the Latest Business Tenders and Contracts Information